NCT00554203View on ClinicalTrials.gov

Sulfasalazine and Endothelial Function

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Coronary Artery Disease
Interventions
DRUG

Sulfasalazine

sulfasalazine 2 grams daily for 6 weeks

Trial Locations (1)

02118

Boston Medical Center, Boston

All Listed Sponsors
lead

Boston University

OTHER

NCT00554203 - Sulfasalazine and Endothelial Function | Biotech Hunter | Biotech Hunter